181
Views
8
CrossRef citations to date
0
Altmetric
Original Research

In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system

, , , , , , , , , & show all
Pages 487-497 | Published online: 22 Jul 2010

References

  • BarbroNMPeterOVivianKJDexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cellsJ Hepatol20003260361110782909
  • SungHKDalWCChoonWKSangGKLack of therapeutic improvement of liver fibrosis in rats by dexamethasone in spite of ascites ameliorationChem Biol Interact2005152374715766921
  • China Pharmacopeial ConventionChinese Pharmacopoeia2005Section 2:184185
  • ZhangZDirkWGrijpmaJFPoly(trimethylene carbonate) and monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) nanoparticles for the controlled release of dexamethasoneJ Control Release200611126327016481063
  • CarolinaGGNicolasTMadeleineBAmelieBEliasFEncapsulation of dexamethasone into biodegradable polymeric nanoparticlesInt J Pharm2007331215315917157461
  • Gomez-GaeteCFattalESilvaLBesnardMTsapisNDexamethasone acetate encapsulation into Trojan particlesJ Control Release20081281414918374442
  • JoshiMDMüllerRHLipid nanoparticles for patrnteral delivery of activesEur J Pharm Biopharm20097116117218824097
  • SunJYZhouZFLiuFChenGSPharmacokinetics and tissue distribution of oxymatrine-SLNChin Pharm J20074210911095
  • YuBTZhangZRZengRJStudy on the liver targeted 5-fluorouracil solid lipid nanoparticlesYao Xue Xue Bao200035704705
  • LuBXiongaSBYangaHYinaXDChaoRBSolid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastasesEur J Pharm Sci200628869516472996
  • LangeMMalyuszMImproved determination of small amounts of free hydroxyproline in biological fluidsClin Chem1994409173517388070084
  • MuLFengSSFabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiersJ Control Release20017623925411578739
  • LuWHeLCWangCHLiYHZhangSQThe use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to miceInt J Biol Macromol20084332032418619484
  • ScholerNOlbrichCTabattKMüllerRHHahnHLiesenfeldOSurfactant, but not the size of solid lipid nanoparticles (SNLC) influences viability and cytokine production of macrophagesInt J Pharm2001221576711397567
  • ScholerNHahnHMüllerRHLiesenfeldOEffect of lipid matrix and size of solid lipid nanoparticles (SNLC) on the viability and cytokine production of macrophagesInt J Pharm200223116717611755269
  • ReddyLHSharmaRKChuttaniKMishraAKMurthyRSREtoposide incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studiesAAPS J20046
  • FundaròACavalliRBargoniAVighettoDZaraGPGascoMRNonstealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacol Res20004233734310987994
  • GertSSheilaOBToosDDaniloDLSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. AdvDrug Deliv Rev1995173148
  • MüllerRHMaaseenSSchwaCMehnertWSolid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytesJ Control Release199747261269
  • JunzoSSatoruSAkiraSHiroshiFHidekiSTadanoriMA nanometer lipid emulsion, lipid nano-sphere (LNS®), as a parenteral drug carrier for passive drug targetingInt J Pharm2004273758315010132
  • RudtSMüllerRHIn vitro phagocytosis assay of nano- and microparticles by chemiluminescence.I. Effect of analytical parameters, particle size and particle concentrationJ Control Release199222263272
  • RudtSMüllerRHIn vitro phagocytosis assay of nano- and microparticles by chemiluminescence.II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptakeJ Control Release1993a255159
  • RudtSMüllerRHIn vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and itscorrelation to particle properties and in vivo distributionEur J Pharm Sci1993b13139
  • LiJCShaXYZhangLJFangXL9-Nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivoYao Xue Xue Bao20054097097516499078
  • EspositoMFantinMMDrechslerLSolid lipid nanoparticles as delivery systems for bromocriptinePharm Res2008251521153018172580
  • QuanDQCuiGHDongHJRuanJXTissue distribution and antiinflammatory activity of dexamethansone acetate incorporated in lipid emulsionJ Chin Pharm Sci2001109093
  • LinHMTsengHCWangCJLinJJLoCWChouFPHepatoprotective effects of Solanum nigrum Linn extract against CCl4-iduced oxidative damage in ratsChem Biol Interact200817128329318045581
  • ParkOJeongWWangLDiverse roles of invariant natural killer T cells in liver injury an fibrosis induced by carbon tetrachlorideHepatology2009491683169419205035
  • FriedmanSLMolecular regulation of hepatic fibrosis, an integrated cellular response to tissue injuryJ Biol Chem200027542247225010644669
  • HuangQZouDJGuoZREffects of dexamethasone on the cultured retroocular fibroblast stimulated by cytokinesChin J Endocrinol Metab200016224227
  • HalilEHayrettinOHulyaOHuseyinBDose-related effects of dexamethasone on liver damage due to bile duct ligation in ratsWorld J Gastroenterol2006125379538316981272
  • MuYLiuPDuGAction mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in ratsJ Ethnopharmacol2009121354218996463